Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1825 (LINC01825)

Target
LINC01825
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 1825 (LINC01825) is a member of the long intergenic non-coding RNA (lincRNA) subclass of long non-coding RNAs. These are RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes. LINC01825, like other lincRNAs, does not encode a protein but is transcribed as an RNA molecule potentially involved in the regulation of gene expression, chromatin architecture, or RNA stability. While the functional characterization of individual lincRNAs is ongoing, this class of molecule is known for regulating gene activity (frequently in a sequence- and context-dependent or gene neighborhood-specific manner), modifying chromatin states, and modulating transcription factor access or stabilization of mRNA. Only a minority of lincRNAs have been experimentally linked to specific diseases or pathways, and for LINC01825, there is currently no evidence supporting a direct disease association or a role as a therapeutic target.

Other names
LINC01825
02

Biological functions

Chromatin remodelingTranscription regulationRNA stabilizationGene expression fine-tuning (especially of neighboring genes)Potential enhancer-like activity
03

Disease associations

Other (For LINC01825 specifically, direct disease associations have not been clearly established, but lincRNAs as a class are implicated in diverse cellular and disease processes including cancer and development)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1825 (LINC01825).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1825 (LINC01825).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call